Rome, Nov 16. (Adnkronos Health) – Supporting initiatives like End of Silence to increase awareness of possible new treatment scenarios for lung cancer is extremely important, especially for a disease like this, which is still rarely discussed and with extreme caution. The message must be direct and scientifically correct, but it must also follow channels that truly reach the entire population, providing information on the characteristics of the disease and its treatment.” So says Silvia Novello, president of Walce (Women Against Lung Cancer in Europe) and Professor of Medical Oncology at the University of Turin and Head of Pulmonary Oncology at the San Luigi Gonzaga Hospital in Orbassano, among the associations supporting the End of Silence campaign, launched in May 2026 and promoted by AstraZeneca to change the narrative on oncological diseases in Italy. The president spoke today at Rome Termini station where an installation was set up using the lyrics of Silvia Salemi’s song as visual micro-stories to tell tales of care and scientific progress.
In recent years, the landscape of lung cancer has profoundly changed thanks to research progress. But it is important that, along with treatment, the way this disease is talked about also evolves, as the president of Walce emphasizes: “Innovation must correspond to perfect education and information.” This is why “strategies and channels to implement the informational aspect are extremely important.” In this regard, “in these twenty years, Walce has embraced the process of educating and informing the population – says Novello – A patient association must keep pace with research, it must stand alongside innovation to inform citizens about changes related to a specific pathology, in this case lung cancer. Having a patient association as a partner in this campaign – she concludes – I would say it is a perfect combination.”